Skip to main content
OpenTrials
Completed

NCT Number: NCT02203214

Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series

The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Gent, Ghent, Belgium

Loading trial locations.

About this study

The Ligamys method was successfully applied in an animal study including eleven white alpine sheep. Healing of the torn ACL and a stable joint without signs of intra-articular damages or osteoarthritis three months postoperative were observed (Kohl KSSTA 2013). In a first clinical study with ten patients, the Ligamys surgical technique resulted in stable clinical and radiological healing of the torn ACL in nine patients with one re-rupture after four months. Nine patients obtained normal knee scores, reported excellent patient satisfaction, and could return to their previous levels of sporting activity (Kohl Swiss Med Wkly 2011).

The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary rupture of the anterior cruciate ligament
  • Signed patient informed consent
  • Willingness to present for follow-up
  • Age between 18 and 50 years at the time of inclusion in the study
  • Injury - surgery time interval of 21 days or less

Exclusion criteria

  • Medical non-compliance
  • Unwillingness to follow the rehabilitation programme
  • Traumatic cartilage lesion requiring cartilage repair procedure (Microfracturing, MACI, ACT) or degenerative cartilage lesions (Outerbridge >ll and defect >1cm2)
  • Non-repairable meniscus lesions requiring a resection of >20%
  • Previous tendon removal on injured leg
  • Relevant permanent medication (Steroids, cytostatic drugs, ...)
  • Pregnancy

Treatment and study plan

Ligamys

Device

All patients are treated with Ligamys within 21 days after injury. The Ligamys implant has to be used in accordance with the instructions for use.

Primary outcomes

  1. Knee stability and function plus safety aspects

    Time frame: 12 months follow-up

    Knee stability: Lachman test Knee function: Lysholm score, IKDC score Safety: ACL re-ruptures or instabilities leading to an implant removal

Secondary outcomes

  1. Patient satisfaction, work absence, activity, pain and secondary degenerative changes of the knee joint

    Time frame: 10 years follow-up

Sponsors and collaborators

Lead sponsor

Mathys Ltd Bettlach

Industry

Registry information

Acronym: Ligamys

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Jul 29, 2014
Registry last updated
Aug 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.